Publication for HMGCS1 and ELOVL6
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 | 3157 | [link] | ||
| hsa | ELOVL6 | ELOVL fatty acid elongase 6 | 79071 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 31159817 | 0.77 | HMGCS1, FDPS, LSS and SQLE) and lipogenic (e.g. ACACA, SCD, FASN, FADS1 and ELOVL6) pathways. |
| 26535575 | 0.54 | ELOVL6, EML1, GINS3 and MVD as well as one out of three transcripts for HMGCS1 did not replicate. |
| 26548416 | 0.53 | Elovl6) and cholesterol (Hmgcr, Hmgcs1, Sqle, Nsdhl, Cyp51 and Egr1) (Fig. 3). |
| 0.53 | ELOVL6, HMGCR, HMGCS1, CYP51, NSDHL, SQLE and SREBP1) was significantly reduced upon treatment with metformin (Fig. 5). |
The preparation time of this page was 0.1 [sec].
